Legend Biotech Corporation American Depositary Shares (LEGN)
Legend Biotech Corporation American Depositary Shares
XNAS:LEGN
28.11
$28.80 - 70.00
$26.01 - 1,300.00
$27.32
$28.97
$27.84
$27.81
45.3
25.71
1711000
1972741.4
180910261.94
Chart
TendieTensor AI Analysis
Company
Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.
Fundamentals
2,800
-21.540000
5.137470
-0.22
100
BBG00TTGH5W4
BBG00TTGH6N2
184.57M
184.57M
Technicals
Short Interest
—
—
—
Higher = harder to cover
—
Prev: —
—
—
5D avg: —
—
Discussion
Login to participate in discussions.
Recent News
Related Stocks
Based on the portfolios of people who own LEGN. This is a list generated by trading data from 3rd party trading platforms, and it's not a recommendation.